Latest News and Press Releases
Want to stay updated on the latest news?
-
Covina, April 27, 2023 (GLOBE NEWSWIRE) -- Dental Stem Cells are convenient and affordable to collect which are used in various therapeutic applications and help in restoring structural defects....
-
EATONTOWN, N.J., Jan. 6, 2014 (GLOBE NEWSWIRE) -- John Arnone, Chairman and CEO of American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented...
-
EATONTOWN, N.J., Nov. 14, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...
-
EATONTOWN, N.J., Sept. 25, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...
-
EATONTOWN, N.J., July 10, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...
-
EATONTOWN, N.J., June 26, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...
-
EATONTOWN, N.J., June 24, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...
-
EATONTOWN, N.J., June 4, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...
-
EATONTOWN, N.J., May 14, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based and cellular...
-
EATONTOWN, N.J., April 23, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...